Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ: HBIO )

0.6479 +0.0078 (+1.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,425,037
Open 0.6500
Bid (Size) 0.6480 (2)
Ask (Size) 0.6918 (1)
Prev. Close 0.6401
Today's Range 0.6020 - 0.6630
52wk Range 0.6020 - 4.700
Shares Outstanding 42,688,246
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire

Performance

YTD
-68.08%
-68.08%
1 Month
-50.54%
-50.54%
3 Month
-70.00%
-70.00%
6 Month
-77.50%
-77.50%
1 Year
-84.90%
-84.90%

More News

Read More
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
From Harvard Bioscience, Inc.
Via GlobeNewswire
Earnings Scheduled For March 12, 2025
Via Benzinga
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Harvard Bioscience Announces Third Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
From Harvard Bioscience, Inc.
Via GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024
Via InvestorPlace
Harvard Bioscience Announces Second Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Holley And 2 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Harvard Bioscience Announces First Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.